Repligen | RGEN - 股票

股票价格

108.52

每天变化

4.32 4.15%

每月一次

-17.78%

每年

-14.95%

Q2 预测

100.80

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 5.81B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	股票	更改		日
Agilent	USD 1.06B		34M	2025-12
Align Technology	USD 214.94M		11.4M	2026-03
Bio Techne	USD 201.18M		4.27M	2026-03
BioMarin Pharmaceutical	USD 1.27B		25.66M	2026-03
Bristol-Myers Squibb	USD 2.76B		66M	2026-03
Bruker	USD 1.12B		26.9M	2026-03
Charles River Laboratories	USD 359.72M		60.62M	2026-03
Danaher	USD 2.61B		119M	2026-03
Dentsply International	USD 659M		17M	2026-03
General Electric Aerospace	USD 12.37B		499M	2026-03
Henry Schein	USD 2.01B		12M	2026-03
Illumina	USD 611M		47M	2026-03
Mettler Toledo International	USD 404.83M		17.6M	2026-03
Myriad Genetics	USD 27.9M		2.7M	2026-03
OraSure Technologies	USD 30.31M		753K	2026-03
Pacific Biosciences Of California	USD 51.02M		1.74M	2026-03
Pfizer	USD 10.67B		13M	2026-03
Repligen	USD 179.26M		8.8M	2026-03
Revvity	USD 387.5M		8.01M	2026-03
Standard Biotools	USD 18.59M		1.39M	2026-03
Thermo Fisher Scientific	USD 5.5B		71M	2026-03
Waters	USD 1.5B		923.63M	2026-03
West Pharmaceutical Services	USD 452.6M		8.7M	2026-03